BANK VONTOBEL/CALL/PFIZER INC/29/0.1/20.12.24 Stock

Warrant

DE000VM7SEQ3

Delayed Deutsche Boerse AG 08:04:41 2024-07-04 EDT
0.127 EUR +4.96% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/29/0.1/20.12.24
Current month-10.37%
1 month-45.74%
Date Price Change
24-07-04 0.127 +4.96%
24-07-03 0.121 -4.72%
24-07-02 0.127 -13.01%
24-07-01 0.146 +8.15%
24-06-28 0.135 +3.05%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 08:04 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM7SEQ
ISINDE000VM7SEQ3
Date issued 2024-01-02
Strike 29 $
Maturity 2024-12-20 (169 Days)
Parity 10 : 1
Emission price 0.29
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.36
Lowest since issue 0.087
Delta0.42x
Omega 8.018
Premium9.96x
Gearing19x
Moneyness 0.9552
Difference Strike 1.3 $
Difference Strike %+4.48%
Spread 0.01
Spread %7.14%
Intrinsic value 0.000000

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus